SARS-COV-2 INFECTION

This study is testing the safety and immune response of a new COVID-19 vaccine designed to target the Omicron JN.1 variant. It will give a single booster dose to about 120 older adults and people with health conditions that put them at high risk for severe COVID-19. All participa…

This study is testing an updated COVID-19 vaccine designed for the 2025-2026 season in children aged 5 to 11 who have a medical condition that puts them at high risk for severe COVID-19. Researchers want to see how safe the vaccine is and how well it triggers an immune response. …

This is an early-stage study testing the safety and immune response of a new vaccine designed to protect against multiple coronaviruses, not just the one that causes COVID-19. The study will enroll 51 healthy adults to receive two doses of the experimental vaccine at different st…

This study is testing an updated COVID-19 vaccine designed for the 2025-2026 virus season. It aims to check the safety and how well it triggers an immune response. The trial is enrolling 760 people aged 12 and older who are at higher risk for severe COVID-19, including all adults…

This is a clinical trial for a medical device that is not yet approved for use. The sponsor has chosen to withhold all specific details about the trial, including what condition it aims to address, how the device works, and who might participate. The purpose of the study is to ga…

This large, long-term study aims to understand why some children and young adults develop lasting health problems after a COVID-19 infection, known as Long COVID or PASC. It will follow over 15,000 participants, both with and without prior infection, to identify risk factors and …

This study aims to understand the long-term health problems some people experience after having COVID-19, often called 'Long COVID.' Researchers will review the medical records of 500 adults who had COVID-19 and were treated at Vanderbilt clinics. The goal is to track recovery pa…

Researchers at the University of Oxford are running a study where they deliberately give a small dose of the Omicron BA.5 COVID-19 virus to healthy, vaccinated volunteers. The goal is to find the right dose that causes a mild, controlled infection in most people, creating a safe …